⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4,4-Difluoro-Piperidinium SCHEMBL1000443 | 0.96 | — | — | |
| 4,4-Difluoro-Piperidinium SCHEMBL29154751 | 0.96 | — | — | |
| 4,4-Difluoro-Piperidinium SCHEMBL19410291 | 0.96 | — | — | |
| 4,4-Difluoro-Piperidinium SCHEMBL16582 | 0.96 | — | — | |
| 4,4-Difluoro-Piperidinium SCHEMBL27142480 | 0.96 | HIF1A (0.33) | — | |
| 4,4-Difluoro-Piperidinium SCHEMBL22288728 | 0.93 | — | — | |
| SCHEMBL2519854 | 0.87 | — | — | |
| 4,4-Difluoro-Piperidinium SCHEMBL28740341 | 0.87 | — | — | |
| SCHEMBL21039320 | 0.85 | CXCR4 (0.42) | — | |
| Hydrochloric Acid SCHEMBL937458 | 0.85 | CXCR4 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4846 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051114-A | Zinc metal negative electrode, preparation method, water-based zinc-based battery and zinc metal soft package battery | 深圳先进技术研究院 | 2026-05-15 | — | — | CN | claimed |
| EP-4568959-A1 | BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2025-06-18 | — | — | EP | claimed |
| CN-120117949-A | Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine | 湖南大学 | 2025-06-10 | — | — | CN | claimed |
| EP-3526209-B1 | HETEROCYCLIC APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF | RES TRIANGLE INST (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119677733-A | Bicyclic tetrahydrothiazepine derivatives | 豪夫迈·罗氏有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119350421-A | Method for preparing arenobufagin carbamate compound by one-pot method | 重庆大学 | 2025-01-24 | — | — | CN | claimed |
| US-20240246940-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | VORONOI INC. (KR) | 2024-07-25 | — | — | US | claimed |
| CN-115386363-B | One-dimensional organic-inorganic hybrid double perovskite fluorescent material and preparation method thereof | 山东大学 | 2024-03-12 | — | — | CN | claimed |
| CN-117560979-A | Perovskite film preparation method and application thereof in solar cell device | 南开大学 | 2024-02-13 | — | — | CN | claimed |
| US-20240018151-A1 | NOVEL INHIBITORS OF PIKFYVE AND METHODS USING SAME | TME THERAPEUTICS LLC | 2024-01-18 | — | — | US | claimed |
| WO-2007057329-A1 | AZAINDOLE-2-CARBOXAMIDE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-05-24 | — | — | WO | claimed |
| EP-1785418-A1 | PYRAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-05-16 | — | — | EP | claimed |
| EP-1762568-A1 | PYRAZOLE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-03-14 | — | — | EP | claimed |
| US-20060189591-A1 | Five-membered heterocyclic derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-08-24 | — | — | US | claimed |
| US-20060128685-A1 | Pyrazole derivative | DAIICHI PHARMACEUTICAL CO., LTD., (JP) | 2006-06-15 | — | — | US | claimed |
| EP-1621537-A1 | FIVE-MEMBERED HETEROCYCLIC DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-02-01 | — | — | EP | claimed |
| EP-1591443-A1 | PYRAZOLE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-11-02 | — | — | EP | claimed |
| EP-1581525-A2 | COMPOUNDS HAVING AN ACTIVITY AT METABOTROPIC GLUTAMATE RECEPTORS | AstraZeneca AB (SE) | 2005-10-05 | — | — | EP | claimed |
| WO-2004014902-A2 | COMPOUNDS HAVING AN ACTIVITY AT METABOTROPIC GLUTAMATE RECEPTORS | ASTRAZENECA AB (SE) | 2004-02-19 | — | — | WO | claimed |
| CN-1085206-C | Benzofurazan compounds which enhance AMPA receptor activity | UNIV CALIFORNIA (US) | 2002-05-22 | — | — | CN | claimed |